Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
The Biomedical and Astronomical Signal Processing (BASP ) laboratory at Heriot-Watt University Edinburgh (HWU ), headed by Professor Yves Wiaux, is recruiting a postdoctoral researcher in computational imaging
-
phytohormones crosstalk and stress signaling pathways in barley”, NCN, OPUS28 No. 2024/55/B/NZ9/00579 Required Qualifications PhD in bioinformatics, plant biotechnology, molecular biology, or a related field
-
casualty care. These projects include closed loop physiological controller development, creating in silico computer models for mimicking human physiology in trauma, and automating ultrasound image
-
Experience in fluorescence microscopy and/or flow cytometry-based readouts of infection Experience with biochemical assays (e.g. Western blotting) Experience handling/processing samples in vivo infection
-
designing and executing the synthesis of novel and innovative foldamer catalysts, and their application towards a variety of stereoselective processes, including organocatalytic and photocatalytic reactions
-
analysis of cell signalling, this three-years postdoc position at DTU Bioengineering will fulfil your scientific and personal development in an international, multi-disciplinary, and curiosity-driven
-
National Aeronautics and Space Administration (NASA) | Pasadena, California | United States | about 7 hours ago
of these worlds. We are interested in how planetary-scale processes such as differentiation, thermal evolution and tidal dissipation affect water, rock and organic chemistry over time, as well as nutrient and
-
… ), paid via bank transfer. Grant holders may be awarded potential supplements, according to a quarterly evaluation process (Articles 19, 21 and 22 of the Regulations for Grants of INESC TEC and Annex II
-
understand, explain and advance society and environment we live in. Your role Conduct research related to the topics of the Signal Transduction Laboratory Participation in teaching activities at Bachelor and
-
inflammatory diseases and exploring immunotherapy to treat them. This exciting project involves characterising samples from a recently completed Phase II clinical trial for amyotrophic lateral sclerosis (ALS